Cancer clinical trials in the region Île-de-France
642 currently recruiting clinical trials
Looking for clinical trials?
Clinical trial search is a complex process, with countless criteria to consider. Our AI assistant navigates this complexity with precise, expert-level analysis of the most relevant trials based on your medical profile. Our database is fully up to date, so you see only actively recruiting sites. It's fast and easy:
- Create your account
- Copy-paste your latest medical report
- Our AI-based assistant does the rest for you
Whether you are a patient or a doctor, create an account to find and apply for the most relevant clinical trials:
Phase 1 / Phase 2
Lymphoma
#NCT05607420
#2022-501607-27-00
Partie escalade de dose
B cell lymphoma
Large B cell lymphoma
Primary mediastinal lymphoma
Mantel cell lymphoma
Follicular lymphoma
Marginal zone lymphoma
MALT lymphoma
Indolent transformed lymphoma
None
2
3 or more
Chemotherapy
Monoclonal antibodies
Systemic Treatment-Naive
Car-T
4 recruiting sites
Cellectis SA
Phase 1 / Phase 2
Lymphoma
#NCT05607420
#2022-501607-27-00
Partie extension de dose
B cell lymphoma
Large B cell lymphoma
Follicular lymphoma
Indolent transformed lymphoma
None
2
3 or more
Chemotherapy
Monoclonal antibodies
Systemic Treatment-Naive
Car-T
4 recruiting sites
Cellectis SA
Phase 1 / Phase 2
Lymphoma
#NCT06495723
#2023-509648-88-00
Escalade et extension de dose
T cell lymphoma
Peripheral T cell lymphoma
None
1
2
3 or more
Chemotherapy
Systemic Treatment-Naive
5 recruiting sites
Xenothera SAS
Phase 1 / Phase 2
Lymphoma
#NCT06090539
B cell lymphoma
Large B cell lymphoma
Follicular lymphoma
Indolent transformed lymphoma
None
2
3 or more
Systemic Treatment-Naive
Car-T
7 recruiting sites
Bristol-Myers Squibb
Phase 1 / Phase 2
Breast cancer
#NCT04626635
#2022-501234-37-00
HER2 Negative
HR Negative
Locally Advanced
Metastatic
1
2
3 or more
Systemic Treatment-Naive
13 recruiting sites
Regeneron Pharmaceuticals
Phase 1 / Phase 2
Lung cancer
#NCT06362252
#2023-509629-36-00
SCLC (Small Cell Lung Cancer)
Metastatic
None
Immunotherapy
Chemotherapy
8 recruiting sites
Daiichi Sankyo
Phase 1 / Phase 2
Lymphoma
CLL & Richter's syndrome
#NCT06542250
#2024-511099-34-00
B cell lymphoma
CLL (Chronic Lymphocytic Leukemia)
Large B cell lymphoma
Mantel cell lymphoma
Follicular lymphoma
Lymphocytic lymphoma
None
2
3 or more
Systemic Treatment-Naive
2 recruiting sites
AstraZeneca
Phase 1 / Phase 2
Liver and bile duct cancer
#NCT04524871
#2023-506611-17-00
Hepatocellular carcinoma
Locally Advanced
Metastatic
Unhealthy
A
None
Systemic Treatment-Naive
Immunotherapy
2 recruiting sites
Hoffmann-La Roche
Phase 1 / Phase 2
Bladder / Urinary Tract / Urethral cancer
#NCT06637423
Non-invasive bladder cancer
Urothelial carcinoma
Localized
1
2
3 or more
Systemic Treatment-Naive
2 recruiting sites
Merck Sharp & Dohme LLC
Phase 1 / Phase 2
Colon cancer
Rectal cancer
#NCT06923761
#2023-504845-30-00
Module 2 Partie D cancer colorectal pMMR/MSS
Locally Advanced
Metastatic
MSS/pMMR
1
2
3 or more
Systemic Treatment-Naive
7 recruiting sites
Grey Wolf Therapeutics